NovaBay Pharma (NBY) Misses Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Research and development: 4K
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Research and development: 4K
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.10), $0.07 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $3.83 million versus the consensus estimate of $3.75 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom credit risk measures rise amid AI financing deals
- H.B. Fuller board rejects Ancora's $1.1B-$1.2B BAS unit bid
- Freedom Broker Starts Citizens Inc. (CIA) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
